Stock & Company Details
Eterna Therapeutics Inc $ERNA
Price:
46,691,331
1.2M
$4.9M
52 Week High:
$66.15
10 Day Average Volume:
42,760,466
-2.21
50 Day Moving Average:
$156.49
52 Week Low:
$43.74
30 Day Average Volume:
49,506,373
$4.94
2021-02-05
0.95
30 Day Change:
13%
3 Month Change:
-0.32%
Health Technology
ERNA technical indicators
Latest Eterna Therapeutics Inc (ERNA) indicator readings as of 2026-08-10.
ERNA's 14-day RSI is 46.8, in neutral territory. At $4.53 it is trading 54.9% above its 200-day moving average of $2.93, and below its 50-day average of $5.92. Price sits in the middle of its Bollinger Bands ($2.31 to $6.83). ADX reads 12.4, indicating a range-bound market rather than a trend.
Select a strategy to see its performance
Backtested on this stock over recent history.
| Strategy | Trend | Return | Win rate |
|---|---|---|---|
| MACD Momentum Momentum Buy when MACD turns positive (crosses above zero) and RSI confirms momentum above 50; sell when MACD falls back below zero. | – | – | |
| RSI Reversal Mean reversion Buy when RSI falls below 30 (oversold), sell when it climbs above 70 (overbought). | – | – | |
| Volatility Breakout Volatility Buy when price closes above the upper Bollinger Band, sell on reversion to the 20-day average. | – | – | |
| Strong-Trend Pullback Trend + timing In strongly trending stocks (ADX above 25), buy short-term dips (Stochastic below 30) and sell into overbought (above 80). | – | – |
Overview
Eterna Therapeutics Inc is a biopharmaceutical company. The company develops transformational new medicines using various cell engineering technology. It is engaged in developing breakthrough mRNA cell engineering technologies to repair cellular dysfunction and treat a range of therapeutic indications. With its strategic partners, the group is developing nucleic acid and cell therapies that can significantly improve the health outcomes of patients with high unmet medical needs.
Finance Bot
Ask your questions
Start by typing a question below.
